CMCER

Canadian Medical Center Co.

4021StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025	Q4 2024Dec 31, 2024
Operations
Operating Cash Flow	10.47M	-0.73M	5.07M	5.07M	6.05M
Free Cash Flow	8.11M	-1.25M	1.83M	1.83M	2.15M
Capital Expenditures	-2.37M	-0.52M	-3.23M	-3.23M	-3.90M
Investing & Financing
Investing Cash Flow	-2.37M	-0.48M	-3.22M	-3.22M	-38.84M
Financing Cash Flow	-4.69M	-0.94M	-2.70M	-2.70M	-0.26M
Dividends Paid	-3.85M	—	-1.93M	-1.93M	—
Operating Activities
Operating Cash Flow	10.47M	-0.73M	5.07M	5.07M	6.05M
Net Income	-1.26M	3.48M	4.14M	4.14M	4.47M
Change in Accounts Payable	6.73M	-2.15M	3.13M	3.13M	0.26M
Change in Accounts Receivable	-2.63M	-6.47M	-5.13M	-5.13M	-3.35M
Change in Inventory	0.62M	-0.15M	-0.45M	-0.45M	1.83M
Change in Other Net Operating Assets	-0.61M	-0.58M	2.45M	2.45M	0.49M
Change in Working Capital	4.11M	-9.35M	-0.00M	-0.00M	-0.77M
Other Operating Activities	1.09M	0.81M	-0.30M	-0.30M	1.31M
Provision & Write-off of Bad Debts	1.12M	0.24M	0.25M	0.25M	-0.03M
Depreciation & Amortization	1.84M	1.73M	1.47M	1.47M	1.13M
Cash Interest Paid	—	—	—	—	—
Investing Activities
Investing Cash Flow	-2.37M	-0.48M	-3.22M	-3.22M	-38.84M
Capital Expenditures	-2.37M	-0.52M	-3.23M	-3.23M	-3.90M
Investment in Securities	—	—	0.01M	0.01M	-35.00M
Sale of Property, Plant & Equipment	—	40.01K	4.35K	4.35K	56.44K
Loss (Gain) From Sale of Assets	—	10.85K	-4.35K	-4.35K	12.19K
Loss (Gain) on Sale of Investments	3.59M	2.34M	-0.49M	-0.49M	-0.07M
Financing Activities
Financing Cash Flow	-4.69M	-0.94M	-2.70M	-2.70M	-0.26M
Common Dividends Paid	-3.85M	—	-1.93M	-1.93M	—
Issuance of Common Stock	—	—	—	—	—
Total Debt Repaid	-0.84M	-0.94M	-0.78M	-0.78M	-0.26M
Net Debt Issued (Repaid)	-0.84M	-0.94M	-0.78M	-0.78M	-0.26M
Free Cash Flow & Returns
Free Cash Flow	8.11M	-1.25M	1.83M	1.83M	2.15M
Free Cash Flow Growth	+277.0%	—	+162.1%	+162.1%	-17.6%
Free Cash Flow Margin	+18.3%	-3.0%	+5.7%	+5.9%	+7.1%
Free Cash Flow Per Share	0.11	-0.02	0.02	0.02	0.03
Levered Free Cash Flow	2.92M	0.43M	—	—	—
Unlevered Free Cash Flow	2.92M	0.56M	—	—	—
Operating Cash Flow Growth	+73.1%	—	+140.1%	+140.1%	+50.4%
Net Cash Flow	3.41M	-2.15M	-0.86M	-0.86M	-33.05M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Quarterly (SAR)

1-5

	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025	Q1 2025Mar 31, 2025	Q4 2024Dec 31, 2024
Operations
Operating Cash Flow	10.47M	-0.73M	5.07M	5.07M	6.05M
Free Cash Flow	8.11M	-1.25M	1.83M	1.83M	2.15M
Capital Expenditures	-2.37M	-0.52M	-3.23M	-3.23M	-3.90M
Investing & Financing
Investing Cash Flow	-2.37M	-0.48M	-3.22M	-3.22M	-38.84M
Financing Cash Flow	-4.69M	-0.94M	-2.70M	-2.70M	-0.26M
Dividends Paid	-3.85M	—	-1.93M	-1.93M	—
Operating Activities
Operating Cash Flow	10.47M	-0.73M	5.07M	5.07M	6.05M
Net Income	-1.26M	3.48M	4.14M	4.14M	4.47M
Change in Accounts Payable	6.73M	-2.15M	3.13M	3.13M	0.26M
Change in Accounts Receivable	-2.63M	-6.47M	-5.13M	-5.13M	-3.35M
Change in Inventory	0.62M	-0.15M	-0.45M	-0.45M	1.83M
Change in Other Net Operating Assets	-0.61M	-0.58M	2.45M	2.45M	0.49M
Change in Working Capital	4.11M	-9.35M	-0.00M	-0.00M	-0.77M
Other Operating Activities	1.09M	0.81M	-0.30M	-0.30M	1.31M
Provision & Write-off of Bad Debts	1.12M	0.24M	0.25M	0.25M	-0.03M
Depreciation & Amortization	1.84M	1.73M	1.47M	1.47M	1.13M
Cash Interest Paid	—	—	—	—	—
Investing Activities
Investing Cash Flow	-2.37M	-0.48M	-3.22M	-3.22M	-38.84M
Capital Expenditures	-2.37M	-0.52M	-3.23M	-3.23M	-3.90M
Investment in Securities	—	—	0.01M	0.01M	-35.00M
Sale of Property, Plant & Equipment	—	40.01K	4.35K	4.35K	56.44K
Loss (Gain) From Sale of Assets	—	10.85K	-4.35K	-4.35K	12.19K
Loss (Gain) on Sale of Investments	3.59M	2.34M	-0.49M	-0.49M	-0.07M
Financing Activities
Financing Cash Flow	-4.69M	-0.94M	-2.70M	-2.70M	-0.26M
Common Dividends Paid	-3.85M	—	-1.93M	-1.93M	—
Issuance of Common Stock	—	—	—	—	—
Total Debt Repaid	-0.84M	-0.94M	-0.78M	-0.78M	-0.26M
Net Debt Issued (Repaid)	-0.84M	-0.94M	-0.78M	-0.78M	-0.26M
Free Cash Flow & Returns
Free Cash Flow	8.11M	-1.25M	1.83M	1.83M	2.15M
Free Cash Flow Growth	+277.0%	—	+162.1%	+162.1%	-17.6%
Free Cash Flow Margin	+18.3%	-3.0%	+5.7%	+5.9%	+7.1%
Free Cash Flow Per Share	0.11	-0.02	0.02	0.02	0.03
Levered Free Cash Flow	2.92M	0.43M	—	—	—
Unlevered Free Cash Flow	2.92M	0.56M	—	—	—
Operating Cash Flow Growth	+73.1%	—	+140.1%	+140.1%	+50.4%
Net Cash Flow	3.41M	-2.15M	-0.86M	-0.86M	-33.05M